Study sheds light on relationship between triple-negative breast cancer cells, immune systems
Reza Shahbazi, PhD, and his research team found that triple-negative breast cancer cells release tiny particles called exosomes that can enter T cells and reprogram how they function.
IU Urology plays key role in national bladder cancer clinical trial
IU’s strong enrollment in the national ABLE-22 trial reflects its commitment to expanding treatment options for patients with BCG-unresponsive bladder cancer.
Globally renowned RNA biologist will share groundbreaking research on Aug. 31
Lynne E. Maquat, the 2026 winner of the Steven C. Beering Award for the Advancement of Biomedical Research, presented by IU School of Medicine, will
Basic science research spotlight: Zainul Hasanali, MD, PhD
Hasanali studies the way plasma cells handle stress in order to understand how plasma cell diseases originate. The ultimate goal of his research is to
IU study finds strategy to beat treatment resistance in the most common childhood cancer
IU School of Medicine cancer researchers have uncovered a potential new way to overcome acute lymphoblastic leukemia (ALL), the most common type of leukemia in
First-generation doctoral student earns Pao-lo Yu Award for excellence in genetics research
From a small mining town to groundbreaking cancer research, her journey reflects resilience, mentorship and a commitment to expanding treatment options for patients.
PhD program in cell, molecular and cancer biology celebrates 10 years in Bloomington
The Cell, Molecular and Cancer Biology PhD program at IU School of Medicine—Bloomington is celebrating its milestone 10th anniversary.
Two-pronged strategy targets core survival systems in treatment-resistant blood cancer
IU researchers have identified a new treatment strategy for acute myeloid leukemia by targeting the blood cancer's survival systems.
IU neurofibromatosis specialist named ASCI Young Physician-Scientist awardee
Steven Rhodes has been honored with the ASCI Young Physician-Scientist Award, which recognizes his dual commitment to advancing NF1 research and providing exceptional care to
Biochemistry professor honored as 2026 ASBMB fellow
Ronald Wek, PhD, the Showalter Professor of Biochemistry at the Indiana University School of Medicine, has been named a 2026 fellow by the American Society